BeyondSpring Inc. Prices Initial Public Offering and Concurrent Private Placement of $54.31 M
/
Date09 Mar 2017
NEW YORK, March 09, 2017 (GLOBE NEWSWIRE) — BeyondSpring Inc. (“BeyondSpring”), a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today... Read More →
Hamilton Lane Announces Closing of its Initial Public Offering
/
Date06 Mar 2017
BALA CYNWYD, Pa., March 06, 2017 (GLOBE NEWSWIRE) — Hamilton Lane Incorporated (NASDAQ:HLNE) (“Hamilton Lane”) today announced the closing of its initial public offering of... Read More →
Evoke Pharma Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
/
Date06 Mar 2017
SOLANA BEACH, Calif., March 06, 2017 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, announced today... Read More →
Applied Optoelectronics Announces Completion of At the Market Offering
/
Date03 Mar 2017
SUGAR LAND, Texas, March 03, 2017 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of fiber-optic access network products for the internet... Read More →
Avis Budget Group Announces Intention to Offer €250 Million of Senior Notes
/
Date01 Mar 2017
PARSIPPANY, N.J., March 01, 2017 (GLOBE NEWSWIRE) — Avis Budget Group, Inc. (NASDAQ:CAR) announced today that its wholly-owned subsidiary, Avis Budget Finance plc, intends, subject... Read More →
Carolina Complete Health Network, Inc. to Conduct Public Offering of Stock
/
Date23 Feb 2017
RALEIGH, N.C., Feb. 23, 2017 (GLOBE NEWSWIRE) — Carolina Complete Health Network, Inc. (CCHN) has been formed as a wholly-owned subsidiary of the North Carolina... Read More →
Ramaco Resources, Inc. Prices Initial Public Offering
/
Date03 Feb 2017
LEXINGTON, Ky., Feb. 02, 2017 (GLOBE NEWSWIRE) — Ramaco Resources, Inc. (NASDAQ:METC) (“Ramaco”) announced today the pricing of its initial public offering of 6,000,000 shares... Read More →
AnaptysBio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
/
Date31 Jan 2017
SAN DIEGO, Jan. 31, 2017 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (NASDAQ:ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs... Read More →
Jounce Therapeutics Announces Pricing of Initial Public Offering
/
Date27 Jan 2017
CAMBRIDGE, Mass., Jan. 26, 2017 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc., a clinical stage company focused on the discovery and development of novel cancer immunotherapies... Read More →
Nasdaq Welcomes ObsEva SA (Nasdaq: OBSV) to The Nasdaq Stock Market
/
Date26 Jan 2017
ObsEva SA (Nasdaq: OBSV) Rings The Nasdaq Stock Market Opening Bell in Celebration of its IPO ObsEva SA (Nasdaq:OBSV), a biopharmaceutical company focused on the... Read More →